AR and prostate cancer: αvβ6 expression is associated with inflammation, and the β6 subunit is increased in cases of benign prostatic hypertrophy [39] as well as in prostate cancer, where αvβ6 has been implicated in controlling prostate cancer growth in conjunction with the androgen receptor [56].